chlorambucil has been researched along with Brain Vascular Disorders in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zelenski, JD | 1 |
Capraro, JA | 1 |
Holden, D | 1 |
Calabrese, LH | 1 |
Conley, CL | 1 |
2 other studies available for chlorambucil and Brain Vascular Disorders
Article | Year |
---|---|
Central nervous system vasculitis in Behçet's syndrome: angiographic improvement after therapy with cytotoxic agents.
Topics: Adult; Antineoplastic Agents; Behcet Syndrome; Cerebral Angiography; Cerebrovascular Disorders; Chlo | 1989 |
Polycythemia vera, diagnosis and treatment.
Topics: Aged; Blood Pressure; Bloodletting; Cerebrovascular Disorders; Chlorambucil; Diagnosis, Differential | 1987 |